AI Drug Patents: Innovation, Ownership & Future Risks
The Innovation Slowdown: Why Rushing to Patent Could Be Killing Breakthroughs Nearly 40% of patented inventions never reach the market. This isn’t a failure of innovation, but a symptom of a growing trend: prioritizing speed to patent over rigorous, real-world testing. As companies increasingly cut corners on in vivo validation, the long-term consequences for research … Read more